Kao-Con LA Tablets
Long-acting potassium chloride tablets (750mg) with wax matrix for 24-hour release, preventing peak-related GI distress while maintaining steady serum potassium levels. HTS 3004.90.92.65 covers this retail medicament designed for chronic prophylactic electrolyte therapy. Provides consistent caloric balance support.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If affecting 11-beta-hydroxylase or similar enzymes
Specific adrenal preparations use distinct subheadings.
If wax/polish preparation dominates over medicament
Polishes and waxes classified in Chapter 34.
If imported as unfinished matrix cores
Unfinished preparations fall under Chapter 38.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Wax matrix integrity tests essential for humidity-sensitive imports
• Demonstrate 24-hour release profile matching US pharmacopeia
• Avoid splitting tablet declarations, as it alters dosing integrity
Related Products under HTS 3004.90.92.65
Potassium Chloride Oral Solution USP
A liquid oral supplement containing potassium chloride in measured doses, used for treating hypokalemia and maintaining electrolyte balance in patients on diuretics. It falls under HTS 3004.90.92.65 as a medicament primarily affecting electrolytic balance, put up for retail sale with potassium chloride as a key ingredient. The preparation is unmixed but dosed precisely for therapeutic use.
K-Dur 20 Extended-Release Tablets
Extended-release potassium chloride tablets (20 mEq) designed for once-daily dosing to prevent potassium deficiency in patients with diuretic-induced hypokalemia. Classified under HTS 3004.90.92.65 due to its mixed formulation primarily affecting electrolytic balance, packaged in retail blister packs. The controlled-release matrix ensures steady electrolyte replenishment.
Klor-Con M10 Powder Packets
Single-dose powder packets of potassium chloride (10 mEq) mixed with flavoring for oral reconstitution in water, used for flexible dosing in outpatient electrolyte therapy. Classified in HTS 3004.90.92.65 as a retail medicament affecting water balance, with precise measured contents. Ideal for patients preferring powder over tablets.
Hyperkalemia Prevention KCl Chewable Tablets
Chewable tablets with potassium chloride for prophylactic use in patients at risk of hypokalemia from prolonged vomiting or renal issues, in fruit-flavored retail packs. Under HTS 3004.90.92.65 as measured-dose preparation regulating electrolytic balance. Easy administration for non-compliant patients.
Potassium Chloride Effervescent Tablets
Effervescent tablets containing potassium chloride that dissolve in water to form an oral solution for rapid electrolyte replacement in hypokalemic patients. This product is under HTS 3004.90.92.65 as it primarily regulates caloric and water balance through potassium supplementation in measured retail doses. The fizzing action aids absorption for therapeutic efficacy.
Micro-K 10 mEq Capsules
Microencapsulated potassium chloride softgel capsules providing 10 mEq per dose for gentle gastrointestinal absorption in electrolyte maintenance therapy. Falls under HTS 3004.90.92.65 for its role in prophylactic potassium replacement, retail-packed in measured units. The microencapsulation minimizes GI irritation common in standard KCl forms.